Product NDC: | 76282-207 |
Proprietary Name: | CITALOPRAM HYDROBROMIDE |
Non Proprietary Name: | CITALOPRAM |
Active Ingredient(s): | 20 mg/1 & nbsp; CITALOPRAM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 76282-207 |
Labeler Name: | Exelan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077534 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121001 |
Package NDC: | 76282-207-01 |
Package Description: | 100 TABLET in 1 BOTTLE (76282-207-01) |
NDC Code | 76282-207-01 |
Proprietary Name | CITALOPRAM HYDROBROMIDE |
Package Description | 100 TABLET in 1 BOTTLE (76282-207-01) |
Product NDC | 76282-207 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CITALOPRAM |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20121001 |
Marketing Category Name | ANDA |
Labeler Name | Exelan Pharmaceuticals Inc. |
Substance Name | CITALOPRAM HYDROBROMIDE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |